One new site opened and 9 new patients randomised!


The trial teams in Jerusalem Shaare Zedek, Trnava, Osaka, Hirakata, Lübeck, Nyon, Bern, London St.George’s and Oslo randomised one new patient each and the new trial site “Lisbon Central” in Portugal was opened. Many thanks and congratulations on this great achievement!